Epigenetic control in rheumatoid arthritis synovial fibroblasts

Nature Reviews Rheumatology

Volumn 5, Issue 5, 2009, Pages 266-272

  Karouzakis, Emmanuel ^a   Gay, Renate E ^a   Gay, Steffen ^a   Neidhart, Michel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; MICRORNA;

CELL CULTURE; DNA METHYLATION; FIBROBLAST; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; UPREGULATION;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROBLASTS; HISTONES; HUMANS; MICRORNAS; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 67650360177     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.55     Document Type: Review

References (52)

1. Eggermann, T., Meyer, E., Caglayan, A. O., Dundar, M. & Schonherr, N. ICRI epimutations in llp15 are restricted to patients with Silver- Russell syndrome features. J. Pediatr. Endocrinol. Metab. 21, 59-62 (2008).
2. Hauke, J. et al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum. Mol. Genet. 18, 304-317 (2009).
3. Gerli, R. et al. Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors. Ann. NY Acad. Sci. 1108, 372-381 (2007).
4. Stoger, R. Epigenetics and obesity. Pharmacogenomics 9, 1851-1860 (2008).
5. Chiang, P K., Lam, M. A. & Luo, Y. The many faces of amyloid 3 in Alzheimer's disease. Curr. Mol. Med. 8, 580-584 (2008).
6. Sokka, T et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res. Ther. 11, R7 (2009).
7. Lu, Q. et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179, 6352-6358 (2007).
8. Javierre, B. M., Esteller, M. & Ballestar, E. Epigenetic connections between autoimmune disorders and haematological malignancies. Trends Immunol. 29, 616-623 (2008).
9. Singal, R. & Ginder, G. D. DNA methylation. Blood 93, 4059-4070 (1999).
10. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
11. Turek-Plewa, J. & Jagodzinski, P. P. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol. Biol. Lett. 10, 631-647 (2005).
12. Issa, J. P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988-993 (2004).
13. Ballestar, E. & Esteller, M. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem. Cell Biol. 83, 374-384 (2005).
14. Robertson, K. D. DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610 (2005).
15. Pountos, I., Corscadden, D., Emery, P. & Giannoudis, P. V. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury 38 (Suppl. 4), S23-S33 (2007).
16. Boquest, A. C., Noer, A. & Collas, P. Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev. 2, 319-329 (2006).
17. Takada, I., Suzawa, M., Matsumoto, K. & Kato, S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann. NY Acad. Sci. 1116, 182-195 (2007).
18. Nolte, S. V., Xu, W., Rennekampff, H. O. & Rodemann, H. P. Diversity of fibroblasts—a review on implications for skin tissue engineering. Cells Tissues Organs 187, 165-176 (2008).
19. Karouzakis, E., Neidhart, M., Gay, R. E. & Gay, S. Molecular and cellular basis of rheumatoid joint destruction. Immunol. Lett. 106, 8-13 (2006).
20. Bauer, S. et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res. Ther. 8, R171 (2006).
21. Muller-Ladner, U., Pap, T., Gay, R. E., Neidhart, M. & Gay, S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 1, 102-110 (2005).
22. Lafyatis, R. et al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-3 and retinoids. J. Clin. Invest. 83, 1267-1276 (1989).
23. Konttinen, Y T. et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 58, 691-697 (1999).
24. v and 33 integrin subunits in cytokine-stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro. Ann. Rheum. Dis. 56, 729-736 (1997).
25. Firestein, G. S., Alvaro-Gracia, J. M. & Maki, R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144, 3347–3353 (1990).
26. Huber, L. C. et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 56, 1087–1093 (2007).
27. Stanczyk, J. et al. Altered expression of μrNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001–1009 (2008).
28. Neidhart, M. et al. retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum. 43, 2634–2647 (2000).
29. Ali, M. et al. Overexpression of transcripts containing LiNe-1 in the synovia of patients with rheumatoid arthritis. Ann. Rheum. Dis. 62, 663–666 (2003).
30. Kuchen, s. et al. The L1 retroelement-related p40 protein induces p38δ MAP kinase. Autoimmunity 37, 57–65 (2004).
31. Karouzakis, e. et al. Genomic hypomethylation of rheumatoid arthritis synovial fibroblasts [abstract 745]. Arthritis Rheum. 56 (Suppl.), s317 (2007).
32. schulz, W. A., steinhoff, C. & Florl, A. R. Methylation of endogenous human retroelements in health and disease. Curr. Top. Microbiol. Immunol. 310, 211–250 (2006).
33. Nile, C. J., Read, R. C., Akil, M., Duff, G. W. & Wilson, A. G. Methylation status of a single CpG site in the IL6 promoter is related to iL-6 messenger rNA levels and rheumatoid arthritis. Arthritis Rheum. 58, 2686–2693 (2008).
34. Kimura, F. et al. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int. J. Cancer 104, 568–578 (2003).
35. Karouzakis, E., Gay, R. E., Kolling, C., Gay, S. & Neidhart, M. Epigenetic profile of gene expression in normal and rheumatoid arthritis synovial fibroblasts [abstract 939]. Arthritis Rheum. 58 (Suppl.), s514 (2008).
36. Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
37. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S. & Neidhart, M. The increased expression of β1 integrin (CD29) in rheumatoid synovial fibroblasts is due to a milieu favouring genomic hypomethylation [abstract OP-0110]. Ann. Rheum. Dis. 67 (Suppl. II), 84 (2008).
38. Hmadcha, A., Bedoya, F. J., Sobrino, F. & Pintado, E. Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production. J. Exp. Med. 190, 1595–1604 (1999).
39. wehbe, H., Henson, R., Meng, F., Mize-Berge, J. & Patel, T. interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res. 66, 10517–10524 (2006).
40. Hodge, D. R. et al. iL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by Akt kinase. Cancer Genomics Proteomics 4, 387–398 (2007).
41. Chuang, L. s. et al. Human DNA-(cytosine-5)- methyltransferase–PCNA complex as a target for p21waf1. Science 277, 1996–2000 (1997).
42. szyf, M. The role of DNA methyltransferase 1 in growth control. Front. Biosci. 6, D599–D609 (2001).
43. Deng, J. & szyf, M. Downregulation of DNA (cytosine-5)-methyltransferase is a late event in NGF-induced PC12 cell differentiation. Brain Res.Mol. Brain Res. 71, 23–31 (1999).
44. Esteller, M. epigenetics in cancer. N. Engl. J. Med. 358, 1148–1159 (2008).
45. Takami, N. et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum. 54, 779–787 (2006).
46. Karouzakis, E., Gay, R. E., Kolling, C., Gay, S. & Neidhart, M. epigenetic approaches to the study of the pathogenesis of rheumatic disease. Eur. Musculoskeletal Rev. 3, 41–43 (2008).
47. Clark, S. J., statham, A., stirzaker, C., Molloy, P. L. & Frommer, M. DNA methylation: bisulphate modification and analysis. Nat. Protoc. 1, 2353–2364 (2006).
48. Tost, J. & Gut, I. G. DNA methylation analysis by pyrosequencing. Nat. Protoc. 2, 2265–2275 (2007).
49. Holemon, H. et al. Methylscreen: DNA methylation density monitoring using quantitative PCr. Biotechniques 43, 683–693 (2007).
50. weber, M. et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39, 457–466 (2007).
51. Mulero-Navarro, S. & Esteller, M. Epigenetic biomarkers for human cancer: the time is now. Crit. Rev. Oncol. Hematol. 68, 1–11 (2008).
52. Butcher, L. M. & Beck, S. Future impact of integrated high-throughput methylome analyses on human health and disease. J. Genet. Genomics 35, 391–401 (2008).